Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JMI-001 PK/PD in Alcohol Hangover
NCT03183297Phase 1Unknown
- Sponsor
- Sen-Jam Pharmaceutical
- Start
- Aug 2017
- Primary completion
- Oct 2017
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of SJP-001 in alcohol hangover (4 arms), sponsored by Sen-Jam Pharmaceutical. Primary endpoints: Maximum Plasma Concentration at 24 hours, Time to Maximum Plasma Concentration at 24 hours and 2 more. Status: unknown.
02
Drugs
SJP-001
03
Conditions
alcohol hangover
Beyond the preview
Go deeper on NCT03183297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03183297.